Exploring the use of cold atmospheric plasma to overcome drug resistance in cancer

dc.contributor.author	Murillo, Dzohara
dc.contributor.author	Huergo, Carmen
dc.contributor.author	Gallego, Borja
dc.contributor.author	Rodríguez González, René
dc.contributor.author	Tornin, Juan
dc.date.accessioned	2023-05-18T08:20:30Z
dc.date.available	2023-05-18T08:20:30Z
dc.date.issued	2023
dc.identifier.citation	Biomedicines, 11(1) (2023); doi:10.3390/biomedicines11010208
dc.identifier.issn	2227-9059
dc.identifier.uri	http://hdl.handle.net/10651/67957
dc.description.sponsorship	Authors acknowledge the financial support of Fundación Alimerka (2022-052-ALIMERKA-TOCAJ), and the Asociación de niños con cancer Galbán de Asturias (grant 2022-101-GALBAN_TOCAJ to JT and RR) and Severo Ochoa predoctoral fellowships (BP-20-046 to B.G. and BP-21-084 to DM).
dc.language.iso	eng
dc.relation.ispartof	Biomedicines
dc.rights	© 2023 by the authors.
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	WOS:000916727500001
dc.title	Exploring the use of cold atmospheric plasma to overcome drug resistance in cancer
dc.type	journal article
dc.identifier.doi	10.3390/biomedicines11010208
dc.relation.projectID	BP-20-046
dc.relation.projectID	BP-21-084
dc.relation.publisherversion	http://dx.doi.org/10.3390/biomedicines11010208
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Artículos [35714]
Bioquímica y Biología Molecular [266]
Investigaciones y Documentos OpenAIRE [7802]
Publicaciones resultado de proyectos financiados con fondos públicos

Este ítem está sujeto a una licencia Creative Commons